Krishna C Alluri
Overview
Explore the profile of Krishna C Alluri including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
241
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Karim N, Miao J, Reckamp K, Gay C, Byers L, Zhao Y, et al.
J Thorac Oncol
. 2024 Nov;
20(3):383-394.
PMID: 39505259
Objective: To evaluate whether the addition of a poly (adenosine diphosphate-ribose) polymerase inhibitor talazoparib to maintenance immune checkpoint inhibitor atezolizumab after frontline chemoimmunotherapy improved outcomes in patients with Schlafen 11...
2.
Seth R, Agarwala S, Messersmith H, Alluri K, Ascierto P, Atkins M, et al.
J Clin Oncol
. 2023 Aug;
41(30):4794-4820.
PMID: 37579248
Purpose: To provide guidance to clinicians regarding the use of systemic therapy for melanoma. Methods: American Society of Clinical Oncology convened an Expert Panel and conducted an updated systematic review...
3.
Seth R, Messersmith H, Kaur V, Kirkwood J, Kudchadkar R, McQuade J, et al.
J Clin Oncol
. 2020 Apr;
38(33):3947-3970.
PMID: 32228358
Purpose: To provide guidance to clinicians regarding the use of systemic therapy for melanoma. Methods: ASCO convened an Expert Panel and conducted a systematic review of the literature. Results: A...
4.
Chirindel A, Alluri K, Chaudhry M, Wahl R, Pawlik T, Herman J, et al.
AJR Am J Roentgenol
. 2015 Apr;
204(5):1093-9.
PMID: 25905947
Objective: The purpose of this study is to evaluate the performance of PET-derived parameters as prognostic markers for overall survival (OS) and progression-free survival (PFS) outcome in patients with pancreatic...
5.
Alluri K, Tahari A, Wahl R, Koch W, Chung C, Subramaniam R
AJR Am J Roentgenol
. 2014 Sep;
203(4):897-903.
PMID: 25247958
Objective: The purpose of this study was to establish the prognostic utility in human papillomavirus (HPV)-positive stage III and IV oropharyngeal squamous cell carcinoma (SCC) of the (18)F-FDG parameters maximal,...
6.
Chirindel A, Alluri K, Tahari A, Chaudhry M, Wahl R, Lodge M, et al.
Clin Nucl Med
. 2014 May;
40(1):e17-22.
PMID: 24873794
Objective: The objective of this study is to establish the magnitude change and interreader reliability of the liver standardized uptake value corrected for lean body mass (SULmean) in dual-time-point imaging...
7.
Subramaniam R, Alluri K, Tahari A, Aygun N, Quon H
J Nucl Med
. 2014 Jan;
55(3):431-8.
PMID: 24408893
Human papillomavirus (HPV)-positive oropharyngeal squamous cell carcinoma (OPSCC) represents an emerging disease that differs from HPV-negative OPSCC in natural history and prognosis. Contrast-enhanced PET/CT is essential to accurately stage the...
8.
Tahari A, Alluri K, Quon H, Koch W, Wahl R, Subramaniam R
Clin Nucl Med
. 2013 Oct;
39(3):225-31.
PMID: 24152652
Objective: The objective of this study was to assess differences in morphological and glycolytic characteristics of primary tumors and locoregional nodal disease between human papillomavirus (HPV)-positive and HPV-negative oropharyngeal head...